Skip to main content

Animations

The Parkinson's Progression Markers Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.


  • Default content image

    Repositioning RFA, A Potential PD Vaccine and PPMI Update

    In the fall 2011 issue of our newsletter, Accelerating the Cure, Nate Herpich, MJFF's associate director of research communications, provided updates on some of our funding.
    Learn more

  • Default content image

    Personal Connections and a Positive Outlook: Checking in with PPMI Control Participant Erika Forte

    Erika Forte is a control participant in PPMI, the Foundation's landmark clinical study to identify biomarkers of Parkinson's disease progression.
    Learn more

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.